Table 2 Experimental cohorts entering the analysis.

From: Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma

 

Group

n

Gender

Age median (min-max) [years]

Training cohort

Healthy donor

20

M = 10

F = 10

67 (51–66)

Multiple myeloma

20

M = 10

F = 10

67 (57–83)

Validation cohort

Healthy donor

20

M = 10

F = 10

56 (54–64)

Multiple myeloma

24

M = 12

F = 12

71 (47–95)

Back to article page